Skip to main content
Journal of Healthcare, Science and the Humanities logoLink to Journal of Healthcare, Science and the Humanities
. 2021 Fall;11(1):149–162.

HIV Testing and Associated Characteristics Among Black Cisgender and Transgender Women in the United States

Jaleah D Rutledge 1, Kaston Anderson-Carpenter 1, Jae Puckett 1
PMCID: PMC9930511  PMID: 36818203

Abstract

Black women in the United States continue to be disproportionately affected by HIV. HIV testing is an important preventative step in the HIV continuum of care, however there is little known about HIV testing among these groups. Therefore, the purpose of this study is to examine the HIV testing behaviors of Black transgender women and explore differences in predictors of HIV testing among Black cisgender and transgender women. This study uses secondary data from the 2014–2017 modules of the Behavioral Risk Factor Surveillance System. Analyses included multiple hierarchical regression. There are no major differences in HIV testing between Black cisgender and transgender women. A number of sociodemographic characteristics have been shown to predict HIV testing among Black cisgender women, but only employment status and age were significant predictors of HIV testing among Black transgender women. A moderation analysis suggested that gender identity significantly moderates the association between employment status and HIV testing such that the relationship between employment status and receiving an HIV test differs by gender identity. The findings of this study highlight nuances in HIV testing among Black cisgender and transgender women that are useful for improving HIV testing as a mode of HIV prevention. Overall, the findings contribute to our understanding of HIV testing practices among Black cisgender and transgender women.

Keywords: HIV testing, Black women, transgender health

Introduction

Current estimates suggest that one in seven transgender (hereafter, trans) women have HIV (Becasen et al., 2018); it is suspected that the rates are even higher among Black trans women (Bukowski et al., 2018), therefore, they are not receiving treatment and are likely to continue to engage in risky sexual behaviors that further contributes to the increased rates of HIV in the Black community. The prevalence of HIV/AIDS among Black women is particularly alarming with Black women comprising 11% of all new HIV diagnoses and 60% of HIV diagnoses among all American women (Centers for Disease Control and Prevention, 2018). In recent years, the rate of infection among Black women has declined but is still significantly higher than other ethnicities (Bradley, 2019).

Trans women, women who were assigned male at birth but currently identify as female, are considered to be high risk for HIV (Clements-Nolle et al., 2001) and are 34 times more likely to acquire HIV in the United States relative to the general population (Baral et al., 2013). Similar to trends among Black cisgender women-women who are assigned female at birth and currently identify as female (hereafter, cis), Black trans women are more susceptible to HIV infection. The literature suggests that of all racial, gender, and sexual minority groups, Black trans women are among the most susceptible to HIV infections and diagnosis (Denson et al., 2017; Herbst et al., 2008; Hwahng & Nuttbrock, 2007). Research attributes the high rates of HIV among Black trans women to factors such as violence, limited access to care, stigma, high levels of engagement in sex work, riskier sexual behavior, substance abuse and intravenous drug use (De Santis, 2009; Wansom et al., n.d.).

The needs of trans communities are distinct and independent from those of other groups, and thus require a separate analysis from the typical, dichotomous understanding of gender (World Health Organization, 2014). Often times, research exploring HIV among trans women has not been distinguished from findings on HIV among men who have sex with men (MSM) (Frye et al., 2015; Golub & Gamarel, 2013; Muessig et al., 2014; Poteat et al., 2016).

HIV research that presents trans women and MSM in the same analysis leaves unanswered whether trans women are at a uniquely higher risk of HIV. It is crucial to conduct HIV research that focuses explicitly on trans women, as studies have demonstrated that discrimination, stigma, and social oppression of individuals with marginalized identities may be a more significant determinant HIV testing and acquisition than the aforementioned risk behaviors (Peterson et al., 2014; Ransome et al., 2016). HIV testing is an important step in prevention, yet there is a gap in the literature concerning HIV testing among Black trans women. In the current study, we aim to describe HIV testing behaviors among Black trans and cis women. Specifically, we examine whether rates of HIV testing vary between Black trans and cis women and whether HIV risk is a particularly strong predictor of HIV testing among these groups. The hypothesis that guides study is informed by an intersectional framework which suggests that multiple social and political identities overlap or intersect to create different forms of advantages or oppression (Crenshaw, 1990). Therefore, we hypothesize 1) Black trans women will be less likely to receive an HIV test than Black cis women, 2) both cis and trans women who engage in high risk behaviors will be less likely to receive an HIV test, and 3) the relationship between the statistically significant sociodemographic predictors and HIV testing will vary by gender identity.

Methods

This study used secondary data from the Behavioral Risk Factor Surveillance System (BRFSS) to examine HIV testing behaviors, the association between sociodemographic factors and HIV testing, and the association between high-risk behaviors and HIV testing among Black cis and trans women. This study received approval from the Institutional Review Board at Michigan State University (MSU STUDY ID: STUDY00003157).

Sample

The sample for this study was constructed from participants in the CDC’s 2014–2017 BRFSS modules, a national telephone survey that assesses health risk in the United States. The 2014–2017 BRFSS modules were administered to non-institutionalized adults (i.e., age ≥ 18) in the United States. Across all four years, there were 1,842,439 participants in the BRFSS modules. Participants were contacted via cell phone and landlines. Disproportionate stratified sampling was used for landline samples and simple random sampling was used for cellular samples. The median response rate for cellphones and landlines 2014–2017 was 46.13% across all states. More information about the methodology of the BRFSS can be found on the BRFSS website (CDC, n.d.). Only self-identified Black women were selected for this study (n = 36,056). A subpopulation of trans women (n =170) was drawn to examine the odds of a lifetime HIV test and associated sociodemographic factors among Black trans women alone.

Measures and Variables

The data for this study focused on sociodemographic characteristics, gender identity, HIV risk, and HIV testing behaviors. Our outcome variable, HIV testing behaviors, is defined as whether or not one has ever received an HIV test. Receiving an HIV test was assessed by one item that assesses if the participant had ever been tested for HIV (yes/no). For gender identity, we created an indicator based on one’s reported sex and gender identity. Participants who identified as female and not transgender received a 0 and participants who identified as female and transgender received a 1. Sociodemographic variables included age, education, income, marital status, employment status, having a primary care provider, receiving delayed healthcare, having health insurance, and metropolitan status. Age was categorized into three groups (i.e., 18–34 years, 35–49 years, 50 years or older).

Education was collapsed into two categories (high school or less, college or more). Income level was defined categorically as less than $20,000, $20,000–$49,999, $50,000–$74,999, and $75,000 or more. Categories for marital status included married/partnered, not married, and widowed. Employment status was measured by four categories: employed, unemployed, retired, and other (i.e., students and home makers). Our indicator for having a primary care provider, receiving delayed healthcare, and having health insurance were each set to 1 if the participant responded yes and 0 if the participant responded no. Metropolitan status was categorized as metropolitan, suburban, and non-metropolitan. HIV risk was assessed only in 2016 and 2017 by one item for which participants responded “yes” certain high-risk behaviors and situations applied to them.

Data Analysis

We summarized participant demographics using weighted proportion descriptive statistics. Hierarchical logistic regression analyses was used to identify the association between the sociodemographic variables and HIV testing and to determine if whether or not the statistically significant associations varied by gender identity. Results from the hierarchical logistic regression models are presented as exponentiated odds ratios and 95% confidence intervals. All analyses were completed using SPSS Version 25, and statistical significance was established at α < .05.

Results

Sociodemographic Characteristics

Table 1 contains sociodemographic statistics of the analytic sample (N = 32,226). Of that number, 99.5% (n = 36,056) were cis women and 0.5% (n = 170) identified as trans women. The sample ranged in age from 18 to 80 years (M = 55.36, SD = 17.09). The majority of the sample was married or partnered (56.3%). Approximately 35.1% of trans women had completed college or more compared to 59.1% of cis women. Among trans women, 47.5% of the sample had an income of $20,000 or less, compared to 28.4% of cis women with an income level of $20,000 or less. Approximately 45.8% of the sample was employed, and 70.9% lived in a metropolitan area.

Table 1.

Sociodemographic characteristics of Black women by gender identity.

Sociodemographic characteristic Cis women n (%) Trans women n (%) Total sample n (%)
Age
 18–34 years 6,109 (16.9) 37 (0.1) 6,146 (17.0)
 35–49 years 7,517 (20.8) 24 (0.07) 7,551 (20.8)
 50+ years 22,420 (61.9) 109 (0.30) 22,529 (62.2%)
Income
 less than $20,000 10,249 (28.3) 66 (0.18) 10,315 (33.1)
 $20,000–$49,999 11,964 (33) 50 (0.14) 12,014 (38.5)
 $50,000–$74,999 3,732 (10.3) 9 (0.02) 3,741 (12.0)
 $75,000+ 5,123 (14.1) 14 (0.04) 5,137 (16.5)
Education Level
 High School or Less 14,698 (40.6) 109 (0.30) 14,807 (40.9)
 College or More 21,256 (58.7) 59 (0.16) 21,315 (58.8)
Employment Status
 Employed 16,402 (45.3) 71 (0.20) 16,473 (45.8)
 Unemployed 7,304 (20.2) 49 (0.14) 7,353 (20.5)
 Retired 9,431 (26.0) 38 (0.10) 9,469 (26.3)
 Other 2,646 (7.3) 12 (0.03) 2,658 (7.4%)
Marital Status
 Married/Partnered 10,635 (28.6) 51 (0.14) 10,686 (29.7)
 Not Married 19,320 (53.3) 93 (0.26) 19,413 (54.0)
 Widowed 5,855 (16.2) 24 (0.07) 5,879 (16.3)
Metropolitan Status
 Metropolitan 15,367 (42.4) 54 (0.15) 15,691 (70.9)
 Suburban 3,122(8.6) 10 (0.03) 3,132 (14.1)
 Non-metropolitan 3,301 (9.1) 19 (0.05) 3,320 (15.0)

Differences in HIV Testing Behaviors among Black Trans and Cis Women

The results indicated that 50% of trans women reported lifetime HIV testing compared to 51.2% of cis women. There was no statistically significant difference in odds of lifetime HIV testing between cis and trans women (see Table 2). Although Black trans women had relatively higher odds of being tested for HIV compared to Black cis women (AOR= 1.01, 95% CI= 0.69–1.47), this finding was not statistically significant.

Table 2.

Regression results for sociodemographic covariates by gender.

Predictor Black Cisgender Women Black Transgender Women Total



AOR 95% CI AOR 95% CI AOR 95% CI
Gender Identity 1.01 (0.69, 1.47)
Age
 18–34 years old -- -- -- -- -- --
 35–49 years old 1.23*** (1.13,1.35) 1.80 (0.41, 7.99) 1.24*** (1.13, 1.35)
 50 years or older 0.30*** (0.28, 0.33) 0.30 (0.09, 1.05) 0.30*** (0.28, 0.33)
Income 0.98 (0.95, 1.01) 0.93 (0.56, 1.55) 0.98 (0.95, 1.01)
Education 1.38*** (1.30, 1.46) 2.44 (0.94, 6.37) 1.38*** (1.30, 1.46)
Employment Status
 Employed -- -- -- -- -- --
 Unemployed 1.06 (0.98, 1.14) 5.71** (1.71, 19.07) 1.06 (0.99, 1.14)
 Retired 0.37*** (0.35, 0.40) 1.74 (0.52, 5.87) 0.38*** (0.35, 0.40)
 Other 0.65*** (0.59, 0.73) 4.50 (0.63, 32.00) 0.66*** (0.59, 0.73)
Marital Status
 Married/Partnered -- -- -- -- -- --
 Not Married 1.30*** (1.22, 1.38) 0.98 (0.34, 2.83) 1.30*** (1.22, 1.38)
 Widowed 0.76*** (0.70, 0.83) 0.61 (0.15, 2.46) 0.76*** (0.70, 0.83)
Metropolitan Status
 Metropolitan -- -- -- -- -- --
 Suburban 0.89** (0.81, 0.97) 3.54 (0.68, 18.47) 0.89* (0.81, 0.97)
 Not Metropolitan 0.61*** (0.56, 0.67) 0.91 (0.25, 3.33) 0.61*** (0.55, 0.67)
Healthcare 1.03 (0.94, 1.14) 1.55 (0.39, 6.21) 1.03 (0.94, 1.14)
Primary Care Provider 1.26*** (1.15, 1.37) 2.21 (0.61, 7.99) 1.26*** (1.16, 1.38)
Delayed Care 1.33*** (1.19, 1.48) 1.13 (0.25, 5.21) 1.33*** (1.19, 1.48)
HIV Risk 2.01*** (1.65, 2.45) 15.09* (1.50, 151.82) 2.05*** (1.69, 2.50)

Note.

*

p < .05;

**

p < .01;

***

p <.001

Factors Associated with HIV Testing among Black Trans Women vs Black Cis Women

Table 2 shows adjusted odds ratios and 95% confidence intervals for predictors of HIV testing in the overall sample and stratified by gender identity. All variables except gender identity, income, unemployment, and health plan were statistically significant predictors of HIV testing in the overall sample. For example, among Black women, those between the ages of 35 and 49 were almost one and one quarter times more likely to receive an HIV test compared to those in the 18–34 age group (AOR: 1.24, 95% CI: 1.13, 1.35). However, Black women 50 years or older were significantly less likely to receive an HIV test (AOR: 0.30, 95% CI: 0.28, 0.33). Additionally, those who had a college education or more showed significantly differential odds of receiving an HIV test (AOR: 1.38, 95% CI: 1.30, 1.46). Black women who were retired (AOR: 0.38 95% CI: 0.35, 0.40), students or homemakers (AOR:0.66, 95% CI: 0.59, 0.73) reported a significantly lower odds of receiving an HIV test compared to Black women who were employed. Compared to Black women who were married or partnered, Black women who were widowed were significantly less likely to receive an HIV test (AOR: 0.76, 95 %CI: 0.70, 0.83) while those who were not married were reported significantly greater odds of receiving an HIV test (AOR: 1.30, 95% CI: 1.22, 1.38) relative to married or partnered Black women. Metropolitan status was a significant predictor in the overall sample such that those in suburban (AOR:0.89, 95% CI: 0.81, 0.97) and other types of non-metropolitan areas (AOR: 0.61, 95% CI: 0.55, 0.67) are significantly less likely to receive an HIV test compared to those in metropolitan areas. Having a primary care provider (AOR: 1.26, 95% CI: 1.16, 1.38), delaying medical care (AOR: 1.33, 95% CI: 1.19, 1.48), and engaging in HIV risk behaviors (AOR: 2.05, 95% CI: 1.69, 2.50) were all associated with having a significantly higher odds of receiving an HIV test.

Stratified analyses showed that predictors of HIV testing among Black cis women were nearly identical to those reported in the overall sample. Compared to employed Black trans women, unemployed Black trans women had a significantly greater odds of having ever received an HIV test (AOR = 4.72; 95% CI = 1.52,14.66). However, unemployment status was not a significant predictor of HIV testing among Black cis women (AOR = 1.06; 95% CI = 0.98,1.14). The significant relationship between HIV risk and HIV testing among Black trans women suggests that Black trans women who are at risk for HIV are significantly more likely to receive an HIV test compared to Black trans women who are not at risk for HIV (AOR = 15.09; 95% CI = 1.50,151.82).

A Moderation Analysis of Sociodemographic Predictors, Gender Identity, and HIV Testing

In addition to examining main effects of sociodemographic characteristics, we also investigated whether gender identity (e.g., cis or trans) moderated the relationship between the statistically significant sociodemographic These results are shown in the second block of Table 3. The model revealed a significant interaction between HIV testing and employment status (retired [AOR: 5.43, 95% CI: 1.73, 17.01] and unemployed [AOR: 4.68, 95% CI: 1.42, 15.46]). A simple slope analysis revealed that employed Black cis women had greater odds of receiving an HIV test than their trans peers, while trans women who were unemployed and retired were significantly more likely to receive an HIV test compared to cis women with similar occupations. It is important to note that this interaction effect only included the employment status of 49 Black trans women.

Table 3.

Hierarchical regression results with interactions.

Predictor Block 1 Block 2

AOR 95% CI AOR 95% CI
Gender Identity 1.01 (0.69, 1.47) 0.10* (0.01, 0.70)
Age
 18–24 years old -- -- -- --
 35–49 years old 1.24*** (1.13, 1.35) 0.86 (0.19, 3.86)
 50 years or older 0.30*** (0.28, 0.33) 0.30 (0.09, 1.06)
Income 0.98 (0.95, 1.01) 0.98 (0.95. 1.01)
Education 1.38*** (1.30, 1.46) 0.79 (0.31, 2.00)
Employment Status
 Employed -- -- -- --
 Unemployed 1.06 (0.99, 1.14) 1.06 (0.98, 1.14)
 Retired 0.38*** (0.35, 0.40) 0.37*** (0.35, 0.40)
 Other 0.66*** (0.59, 0.73) 0.65*** (0.59, 0.73)
Marital Status
 Married/Partnered -- -- -- --
 Not Married 1.30*** (1.22, 1.38) 1.73 (0.65, 4.59)
 Widowed 0.76*** (0.70, 0.83) 0.92 (0.23 3.64)
Metropolitan Status
 Metropolitan -- -- -- --
 Suburban 0.89* (0.81, 0.97) 0.22 (0.04, 1.13)
 Not Metropolitan 0.61*** (0.55, 0.67) 0.42 (0.11, 1.53)
Healthcare 1.03 (0.94, 1.14) 1.03 (0.94, 1.14)
Primary Care Provider 1.26*** (1.16, 1.38) 0.61 (0.19, 2.01)
Delay Care 1.33*** (1.19, 1.48) 1.55 (0.33, 7.24)
Risk 2.05*** (1.69, 2.50) 0.27 (0.03, 2.87)
Gender Identity × Age
 18–34 years old -- -- -- --
 35–49 years old 1.43 (0.32, 6.32)
 50 years or older 1.00 (0.29, 3.51)
Gender Identity × Education 1.74 (0.69, 4.39)
Gender Identity × Employment Status
 Employed -- -- -- --
 Unemployed 5.43** (1.73, 17.01)
 Retired 4.68* (1.42, 15.46)
 Other 6.52 (0.97, 44.03)
Group × Marital Status
 Married -- -- -- --
 Not Married 0.75 (0.29, 2.00)
 Widowed 0.83 (0.21, 3.25)
Gender Identity × Metropolitan Status
 Metropolitan -- -- -- --
 Suburban 4.08 (0.79, 21.11)
 Not Metropolitan 1.46 (0.40, 5.28)
Gender Identity × Delay Care 0.86 (0.19, 3.96)
Gender Identity × Risk 7.33 (0.72, 74.78)

Note.

*

p < .05;

**

p < .01;

***

p <.001

Discussion

Guided by an intersectional approach, this study explored HIV testing behaviors of Black trans women and compared them to testing behaviors among Black cis women. For this study, HIV testing behaviors were defined as a person having received an HIV test at least once in their life. Furthermore, the study examined HIV risk as a predictor of HIV testing, while also identifying sociodemographic factors associated with HIV testing behaviors and if they were moderated by gender identity. Our findings generally do not support our hypotheses. Although prior studies suggest that Black trans women are disproportionately affected by a number of structural factors that contribute to increased HIV vulnerability and HIV diagnosis (Clements-Nolle et al., 2001; Herbst et al., 2008), results of this study contradict previous reports on correlates of HIV testing among trans women (Logie et al., 2016; Rutledge et al., 2018). Our identification of HIV risk as a significant predictor of HIV testing is also inconsistent with prior literature on the association between HIV risk and HIV testing which identify HIV risk as a barrier to HIV testing (Dailey et al., 2017; Mills et al., 2011).

The results revealed some interesting information regarding the association between age and HIV testing. The multivariable logistic regression models suggest that older Black trans women and Black cis women were less likely to receive an HIV test compared to Black cis and trans women within the 18–34 year old age range. This result is consistent with previous literature that suggests that older adults are less likely to receive an HIV test (Akers et al., 2008; Wigfall et al., 2011). Findings by other researchers attributed low testing rates among older adults to factors such as limited knowledge, and low self-perceived risk (Guo & Sims, 2017).

Gender identity was not shown as a predictor or moderator of HIV testing, which was anticipated based off of trans women’s disproportionate burden of HIV (Baral et al., 2013; Herbst et al., 2008) and their unique vulnerability to HIV (Hwahng & Nuttbrock, 2007; Poteat et al., 2014). Besides HIV risk, unemployment was the only covariate that emerged as a significant predictor of HIV testing among Black trans women. Consistent with previous literature on unemployment and HIV testing (Brown et al., 2007), Black trans women who were unemployed were almost five times more likely to have received an HIV test in their lifetime compared to Black trans women who were employed. The relationship between employment status and receiving an HIV test among cis women indicated that cis women who were retired or had other types of employment (e.g., homemakers or students) were significantly less likely to receive an HIV test relative to employed cis women. It is also worthwhile to note that because some types of self-employment are nontraditional (e.g., sex work), there could be variation in how respondents classified their own employment status. Overall, the association between HIV testing and employment status has been inconsistent in previous literature. On one hand, employment status has not been shown to be a significant predictor among Black people (Benavides-Torres et al., 2012), while other studies suggest that Black people who were employed were more likely to have ever received an HIV test compared to those who were unemployed (Funk et al., 2018).

Limitations

There are several limitations to consider for this study. One major limitation is that all data in this study was self-reported. While the BRFSS has been shown to be a reliable and useful dataset for HIV testing research (Rountree et al., 2009), participants may have reported inaccurate responses due to issues such as recall bias or social desirability. It is also important to note that because the BRFSS collects data via landline and cellular phones, those who do not have access to a landline or cellular phone are not represented in this data (e.g., those who are institutionalized). As previously mentioned, the way that the BRFSS measured HIV risk is also a major limitation. The BRFSS used one item to assess HIV risk, which only asked participants to respond yes or no if they participated in any of the risk behaviors that were stated. This item may not have adequately captured the complex nature of risk. Other studies have found variability in the ways that different types of risk behaviors are associated with HIV risk (Emmanuel & Link to external site, 2019).

Because this was a secondary data analysis, the analysis was limited to the questions that were assessed by BRFSS. Given this, some of the important perspectives that have been shown to greatly influence the well-being of Black women were not captured in this study. For example, the BRFSS did not gather any information on experiences of discrimination in healthcare settings. In addition to conducting bivariate analyses of health outcomes of intersectional groups, gathering information on discrimination has been shown to be an important component of taking an intersectional approach (Bauer & Scheim, 2019). Having information on experiences of discrimination would have been useful for further developing the intersectional grounding of this study.

Conclusion

The results of this study provide information that can help public health practitioners with the development of HIV testing initiatives that address the needs of two historically marginalized populations. The varied number of sociodemographic predictors that emerged as statistically significant predictors of HIV testing suggest that HIV testing interventions should not be “one-size-fits-all”. Public health professionals should consider developing testing interventions that are tailored to the specific needs of Black cis and trans women. These interventions should be guided by an understanding of how different sociodemographic factors are associated with HIV testing. The information provided in this study may help public health professionals in terms of developing resources and providing guidance for vulnerable and diverse populations concerning HIV testing. Furthermore, knowing which sociodemographic groups are not getting tested increases the ability of public health professionals to be able to target these groups. For example, knowing that Black trans women who are employed have lower odds of getting tested compared to those who are unemployed, retired, students, or homemakers may motivate public health practitioners to begin exploring ways to increase testing among employed Black trans women. More research is needed to better understand the interaction between employment, gender identity, and HIV testing.

Footnotes

Author Note

This study received approval from the Institutional Review Board at Michigan State University (MSU STUDY ID: STUDY00003157). I would like to thank my committee members Drs. Kaston Anderson-Carpenter, William Chopik, Ignacio Acevedo Polakovich, and Jae Puckett for their support and guidance on this project. I have no conflicts of interest to declare.

References

  1. Akers AY, Bernstein L, Doyle J, Corbie-Smith G. Older Women and HIV Testing: Examining the Relationship Between HIV Testing History, Age, and Lifetime HIV Risk Behaviors. Sexually Transmitted Diseases. 2008;35(4):420–423. doi: 10.1097/OLQ.0b013e3181644b39. [DOI] [PubMed] [Google Scholar]
  2. Baral SD, Poteat T, Strömdahl S, Wirtz AL, Guadamuz TE, Beyrer C. Worldwide burden of HIV in transgender women: A systematic review and metaanalysis. The Lancet Infectious Diseases. 2013;13(3):214–222. doi: 10.1016/S1473-3099(12)70315-8. [DOI] [PubMed] [Google Scholar]
  3. Bauer GR, Scheim AI. Methods for analytic intercategorical intersectionality in quantitative research: Discrimination as a mediator of health inequalities. Social Science & Medicine. 2019;226:236–245. doi: 10.1016/j.socscimed.2018.12.015. [DOI] [PubMed] [Google Scholar]
  4. Becasen JS, Denard CL, Mullins MM, Higa DH, Sipe TA. Estimating the Prevalence of HIV and Sexual Behaviors Among the US Transgender Population: A Systematic Review and Meta-Analysis, 2006–2017. American Journal of Public Health. 2018;109(1):e1–e8. doi: 10.2105/AJPH.2018.304727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Benavides-Torres RA, Wall KM, Núñez Rocha GM, Onofre Rodríguez DJ, Hopson L. Factors Associated with Lifetime HIV Testing in Texas by Race/Ethnicity. The Open AIDS Journal. 2012;6:232–238. doi: 10.2174/1874613601206010232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bradley ELP. Disparities in Incidence of Human Immunodeficiency Virus Infection Among Black and White Women—United States, 2010–2016. MMWR Morbidity and Mortality Weekly Report. 2019;68 doi: 10.15585/mmwr.mm6818a3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Brown NC, Taylor ED, Mulatu MS, Scott W. Demographic correlates of HIV testing, high-risk behaviors, and condom/STD consultation among a multi-ethnic sample of women. Women & Health. 2007;46(2–3):59–76. doi: 10.1300/J013v46n02_05. [DOI] [PubMed] [Google Scholar]
  8. Bukowski LA, Chandler CJ, Creasy SL, Matthews DD, Friedman MR, Stall RD. Characterizing the HIV Care Continuum and Identifying Barriers and Facilitators to HIV Diagnosis and Viral Suppression Among Black Transgender Women in the United States. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2018;79(4):413–420. doi: 10.1097/QAI.0000000000001831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Centers for Disease Control and Prevention [CDC] About BRFSS. n.d. 2019. Feb 9, Retrieved from https://www.cdc.gov/brfss/about/index.htm.
  10. Centers for Disease Control and Prevention. HIV Surveillance Report 2017. 2018;29:129. [Google Scholar]
  11. Clements-Nolle K, Marx R, Guzman R, Katz M. HIV prevalence, risk behaviors, health care use, and mental health status of transgender persons: Implications for public health intervention. American Journal of Public Health. 2001;91(6):915–921. doi: 10.2105/ajph.91.6.915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Crenshaw K. Mapping the Margins: Intersectionality, Identity Politics, and Violence against Women of Color. Stanford Law Review. 1990;43(6):1241–1300. [Google Scholar]
  13. Dailey AF, Hoots BE, Hall HI, Song R, Hayes D, Fulton P, Prejean J, Hernandez AL, Koenig LJ, Valleroy LA. Vital Signs: Human Immunodeficiency Virus Testing and Diagnosis Delays — United States. MMWR Morbidity and Mortality Weekly Report. 2017;66(47):1300–1306. doi: 10.15585/mmwr.mm6647e1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. De Santis JP. HIV Infection Risk Factors Among Male-to-Female Transgender Persons: A Review of the Literature. Journal of the Association of Nurses in AIDS Care. 2009;20(5):362–372. doi: 10.1016/j.jana.2009.06.005. [DOI] [PubMed] [Google Scholar]
  15. Denson DJ, Padgett PM, Pitts N, Paz-Bailey G, Bingham T, Carlos J-A, McCann P, Prachand N, Risser J, Finlayson T. Health Care Use and HIV-Related Behaviors of Black and Latina Transgender Women in 3 US Metropolitan Areas: Results From the Transgender HIV Behavioral Survey. Journal of Acquired Immune Deficiency Syndromes (1999) 2017;75(Suppl 3):S268–S275. doi: 10.1097/QAI.0000000000001402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Emmanuel AD. Exploring the Relationship between HIV Risk Behaviors and HIV Testing among Youth. Ph.D. The George Washington University; 2019. Link to external site, this link will open in a new window. https://search.proquest.com/docview/2203415223/abstract/C907F08EC24E4CCAPQ/1 . [Google Scholar]
  17. Frye V, Wilton L, Hirshfield S, Chiasson MA, Usher D, Lucy D, McCrossin J, Greene E, Koblin B. “Just Because It’s Out There, People Aren’t Going to Use It.” HIV Self-Testing Among Young, Black MSM, and Transgender Women. AIDS Patient Care and STDs. 2015;29(11):617–624. doi: 10.1089/apc.2015.0100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Funk AN, Inungu JN, Leveille ER, Minelli M. Factors Associated with HIV-Testing among African Americans: Analysis of the 2016 National Health Interview Survey. European Journal of Environment and Public Health. 2018;2(1):03. doi: 10.20897/ejeph/82621. [DOI] [Google Scholar]
  19. Golub SA, Gamarel KE. The Impact of Anticipated HIV Stigma on Delays in HIV Testing Behaviors: Findings from a Community-Based Sample of Men Who Have Sex with Men and Transgender Women in New York City. AIDS Patient Care and STDs. 2013;27(11):621–627. doi: 10.1089/apc.2013.0245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Guo Y, Sims OT. Assessment of recent HIV testing among older adults in the United States. Social Work in Health Care. 2017;56(9):855–864. doi: 10.1080/00981389.2017.1339762. [DOI] [PubMed] [Google Scholar]
  21. Herbst JH, Jacobs ED, Finlayson TJ, McKleroy VS, Neumann MS, Crepaz N for the HIV/AIDS Prevention Research Synthesis Team. Estimating HIV Prevalence and Risk Behaviors of Transgender Persons in the United States: A Systematic Review. AIDS and Behavior. 2008;12(1):1–17. doi: 10.1007/s10461-007-9299-3. [DOI] [PubMed] [Google Scholar]
  22. Hwahng SJ, Nuttbrock L. Sex workers, fem queens, and cross-dressers: Differential marginalizations and HIV vulnerabilities among three ethnocultural male-to-female transgender communities in New York City. Sexuality Research & Social Policy. 2007;4(4):36. doi: 10.1525/srsp.2007.4.4.36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Logie CH, Lacombe-Duncan A, Wang Y, Jones N, Levermore K, Neil A, Ellis T, Bryan N, Harker S, Marshall A, Newman PA. Prevalence and Correlates of HIV Infection and HIV Testing Among Transgender Women in Jamaica. AIDS Patient Care and STDs. 2016;30(9):416–424. doi: 10.1089/apc.2016.0145. [DOI] [PubMed] [Google Scholar]
  24. Mills CW, Sabharwal CJ, Udeagu C-C, Bocour A, Bodach S, Shepard C, Begier EM. Barriers to HIV Testing Among HIV/AIDS Concurrently Diagnosed Persons in New York City. Sexually Transmitted Diseases. 2011;38(8):715–721. doi: 10.1097/OLQ.0b013e31820ead73. [DOI] [PubMed] [Google Scholar]
  25. Muessig KE, Baltierra NB, Pike EC, LeGrand S, Hightow-Weidman LB. Achieving HIV risk reduction through HealthMpowerment.org, a user-driven eHealth intervention for young Black men who have sex with men and transgender women who have sex with men. Digital Culture & Education. 2014;6(3):164–182. [PMC free article] [PubMed] [Google Scholar]
  26. Peterson JL, Bakeman R, Sullivan P, Millett G, Rosenberg E, Salazar L, Di Clemente RJ, Cooper H, Kelley CF, Mulligan MJ, Frew P, del Rio C. Social Discrimination and Resiliency are not associated with Differences in Prevalent HIV Infection in Black and White Men who have Sex with Men. Journal of Acquired Immune Deficiency Syndromes (1999) 2014;66(5):538–543. doi: 10.1097/QAI.0000000000000203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Poteat T, German D, Flynn C. The conflation of gender and sex: Gaps and opportunities in HIV data among transgender women and MSM. Global Public Health. 2016;11(7–8):835–848. doi: 10.1080/17441692.2015.1134615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Poteat T, Reisner SL, Radix A. HIV Epidemics among Transgender Women. Current Opinion in HIV and AIDS. 2014;9(2):168–173. doi: 10.1097/COH.0000000000000030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Ransome Y, Kawachi I, Braunstein S, Nash D. Structural inequalities drive late HIV diagnosis: The role of black racial concentration, income inequality, socioeconomic deprivation, and HIV testing. Health & Place. 2016;242:148–158. doi: 10.1016/j.healthplace.2016.09.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Rountree MA, Chen L, Brown A, Pomeroy EC. HIV Testing Rates and Testing Locations, by Race and Ethnicity. Health & Social Work. 2009;34(4):247–255. doi: 10.1093/hsw/34.4.247. [DOI] [PubMed] [Google Scholar]
  31. Rutledge R, Morozova O, Gibson BA, Altice FL, Kamarulzaman A, Wickersham JA. Correlates of Recent HIV Testing Among Transgender Women in Greater Kuala Lumpur, Malaysia. LGBT Health. 2018;5(8):484–493. doi: 10.1089/lgbt.2018.0021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Wansom T, Guadamuz TE, Vasan S., (nd) Transgender populations and HIV: Unique risks, challenges and opportunities. Journal of Virus Eradication. 2(2):87–93. [PMC free article] [PubMed] [Google Scholar]
  33. Wigfall LT, Richter DL, Torres ME, Annang L, Lindley LL, Swayampakala K, Sebastian N, Glover SH, Duffus WA. HIV Testing Among Midlife Women in the Deep South: An Analysis of the 2008 Behavioral Risk Factor Surveillance System Survey Data. Journal of Women’s Health. 2011;20(6):933–941. doi: 10.1089/jwh.2010.2096. [DOI] [PubMed] [Google Scholar]
  34. World Health Organization. Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations. World Health Organization; 2014. [PubMed] [Google Scholar]

Articles from Journal of Healthcare, Science and the Humanities are provided here courtesy of National Center for Bioethics in Health Care, Tuskegee University

RESOURCES